Lunai Bioworks Inc. Income Taxes Paid
Lunai Bioworks Inc. (LNAI) reported Income Taxes Paid of $0 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2025-09-29
- Lunai Bioworks Inc. income taxes paid, net for the quarter ending 2024-06-30 was $0.00.
- Lunai Bioworks Inc. income taxes paid, net for the quarter ending 2023-06-30 was $0.00.
- Lunai Bioworks Inc. income taxes paid, net for the quarter ending 2022-06-30 was $0.00.
- Lunai Bioworks Inc. income taxes paid, net for the quarter ending 2022-03-31 was $0.00.
- Lunai Bioworks Inc. income taxes paid, net for fiscal 2025 was $0.00.
- Lunai Bioworks Inc. income taxes paid, net for fiscal 2024 was $0.00.
- Lunai Bioworks Inc. income taxes paid, net for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Lunai Bioworks Inc. income taxes paid, net for fiscal 2022 was $34.00, a 8.11% decline from fiscal 2021.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-K · filed 2025-09-29 | |||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-29 | $0.00 10-K · filed 2025-09-29 | ||
| 2024-03-31 | $0.00 10-Q/A · filed 2025-02-19 | |||
| 2023-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | $0.00 10-K/A · filed 2025-02-19 | ||
| 2023-03-31 | $0.00 10-Q/A · filed 2025-02-19 | |||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-02 | $0.00 derived: sum of 2 quarters · filed 2023-10-02 | $0.00 derived: sum of 3 quarters · filed 2023-10-02 | $34.00 10-K · filed 2023-10-02 |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $34.00 10-Q · filed 2023-05-12 | $34.00 derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-09 | $34.00 10-Q · filed 2023-03-09 | $34.00 derived: sum of 3 quarters · filed 2023-03-09 | $34.00 derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-09-30 | $34.00 10-Q · filed 2023-03-07 | $34.00 derived: sum of 2 quarters · filed 2023-03-07 | $34.00 derived: sum of 3 quarters · filed 2023-03-07 | $34.00 derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $37.00 10-K · filed 2023-02-27 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $37.00 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $37.00 10-Q · filed 2022-02-14 | ||
| 2020-09-30 | $37.00 10-Q · filed 2021-11-15 | |||
| 2017-06-30 | $64.00K 10-K · filed 2018-10-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |